人胚胎干细胞专利授权中的伦理障碍——从城户常雄专利申请在中、美、日、欧的审查谈起  

Ethical Barriers in Licensing Human Embryonic Stem Cells——Start from the Examination of Toshiro Tojo′s Patent Application in China, the United States, Japan and Europe

作　　者：王媛媛 闫文军 WANG Yuan-yuan;YAN Wen-jun(Intellectual Property School,University of Chinese Academy of Sciences,Beijing 100049,China)

机构地区：[1]中国科学院大学知识产权学院

出　　处：《科技与法律》2019年第3期66-73,共8页Science Technology and Law

基　　金：中科院学部咨询项目“依法治国中科学技术发挥的作用和相关制度研究”子课题(6JT01DJ01)

摘　　要：从城户常雄专利申请在中、美、日、欧的审查可以看出,我国对于人胚胎干细胞的专利授权条件是最为严格的。这不利于我国对于人胚胎干细胞的研究和相关产业发展。建议放宽专利授权中的伦理审查标准,使专利授权中的伦理审查与科学研究中的伦理准则一致,限制人胚胎的范围,允许从商业途径获得的胚胎干细胞获得专利,对专利申请中的"免责声明"进行具体分析。From the examination of Toshiro Tojo′s patent application in China,the United States,Japan and Europe,it can be seen that the patent licensing conditions for human embryonic stem cells in China are the most stringent.This is not conducive to China′s research on human embryonic stem cells and related industry development.It is recommended to relax the ethical examination standards in patent licensing,make the ethical examination in patent licensing consistent with the ethical guidelines in scientific research,limit the scope of human embryos,allow the patents of embryonic stem cells obtained from commercial channels,and make specific analysis of the"disclaimer"in the patent application.

关 键 词：人胚胎干细胞 专利 伦理 社会公德 审查指南 

分 类 号：D913.4[政治法律—民商法学]